Angiopoetin
Agonisti: Angiopoetin 1
Angiopoetin 4
Antagonisti: Angiopoetin 2
Angiopoetin 3
Inhibitori kinaze : Altiratinib
CE-245677
Rebastinib
Antitijela : Evinacumab (protiv angiopoetina 3)
Nesvacumab (protiv angiopoetina 2)
CNTF
Agonist: Agzokin
CNTF
Dapiclermin
EGF (ErbB)
EGF (ErbB1/HER1)
Agonisti: Amfiregulin
EGF (urogastron)
Epigen* Epiregulin
HB-EGF
Murodermin
Nepidermin
TGFα
Inhibitori kinaze : Afatinib
Agerafenib
Brigatinib
Canertinib
Dacomitinib
Erlotinib
Gefitinib
Grandinin
Icotinib
Lapatinib
Neratinib
Osimertinib
Vandetanib
WHI-P 154
Antitijela : Cetuksimab
Depatuksizumab
Depatuksizumab mafodotin
Futuksimab
Imgatuzumab
Matuzumab
Necitumumab
Nimotuzumab
Panitumumab
Zalutumumab
ErbB2/HER2
Agonisti: Nepoznati/nema
Antitijela : Ertumaksomab
Pertuzumab
Trastuzumab
Trastuzumab-derukstekan
Trastuzumab-duokarmazin
Trastuzumab-emtanzin
Inhibitori kinaze : Afatinib
Lapatinib
Mubritinib
Tucatinib
ErbB3/HER3
Agonisti: Neuregulini (heregulini) (1, 2, 6 (neuroglikan C))
Antitijela : Duligotumab
Patritumab
Seribantumab
ErbB4/HER4
Agonisti: Betacelulin
Epigen
HHB-EGF
Neuregulini (heregulini) (1, 2, 3, 4, 5 (tomoregulin, TMEFF)
FGF
FGFR1
Agonisti: Erzofermin
FGF (1 , 2 (bFGF), 3, 4, 5, 6, 8, 10 (KGF2), 20)
Repifermin
Selperkatinib
Trafermin
Velafermin
FGFR2
Agonisti: Erzofermin
FGF (1 , 2 (bFGF) , 3, 4, 5, 6, 7 (KGF), 8, 9, 10 (KGF2), 17, 18, 22)
Palifermin
Repifermin
Selpercatinib
Sprifermin
Trafermin
Antitijela : Aprutumab
Aprutumab-iksadotin
Inhibitori kinaze : Infigratinib
FGFR3
Agonisti: Ersofermin
FGF (1 , 2 (bFGF), 4, 8, 9, 18, 23)
Selperkatinib
Sprifermin
Trafermin
Antitijela : Burosumab (protiv FGF23)
FGFR4
Agonisti: Ersofermin
FGF (1 , 2 (bFGF), 4, 6, 8, 9, 19)
Trafermin
Neraspoređeni
HGF (c-Met)
Agonisti: Hepatocitni faktor rasta
Potencijatori: Diheksa (PNB-0408)
Inhibitori kinaze : Altiratinib
AM7
AMG-458
Amuvatinib
BMS-777607
Foretinib
Golvatinib
INCB28060
JNJ-38877605
K252a
Kabozantinib
Kapmatinib
MK-2461
PF-04217903
PF-2341066
PHA-665752
SU-11274
Tivantinib
Volitinib
Antitijela : Emibetuzumab
Fiklatuzumab
Flanvotumab
Onartuzumab
Rilotumumab
Telisotuzumab
Telisotuzumab vedotin
IGF
IGF-1
Agonisti: des(1-3)IGF-1
Somatomedin C
IGF-1 LR3
Somatomedin A
Insulin
Mekazermin
Mekazermin-rinfabat
Inhibitori kinaze BMS-754807
Linsitinib
NVP-ADW742
NVP-AEW541
OSl-906
Antitijela : AVE-1642
Ciksutumumab
Dalotuzumab
Figitumumab
Ganitumab
Robatumumab
R1507
Teprotumumab
Ksentuzumab (protiv IGF-1 i IGF-2)
IGF-2 Ostali
Vezujući proteini : IGFBP (1, 2, 3, 4, 5, 6, 7)
Proizvodi razlaganja/izvedenice nepoznatog cilja: Glipromat (GPE, (1-3)IGF-1)
Trofinetid
LNGF (p75NTR )
Agoniststi: BDNF
BNN-20
BNN-27
Cenegermin
DHEA
DHEA-S
NGF
NT-3
NT-4
Antagonisti: ALE-0540
Deksametazon
EVT-901 (SAR-127963)
Testosteron
Antitijela : NGF: ABT-110 (PG110)
ASP-6294
Fazinumab
Frunevetmab
Fulranumab
MEDI-578
Ranevetmab
Tanezumab
Aptameri: protiv NGF: RBM-004
Mamac-receptori: LEVI-04 (p75NTR -Fc)
receptor PDGF
Agonists: Bekaplermin
Trobocitni (A, B , C, D)
Inhibitori kinaze : Agerafenib
Avapritinib
Aksitinib
Krenolanib
Imatinib
Lenvatinib
Masitinib
Motesanib
Nintedanib
Pazopanib
Radotinib
Kvizartinib
Ripretinib
Sunitinib
Sorafenib
Toceranib
Antitijela : Olaratumab
Ramucirumab
Tovetumab
RET (GFL)
GFRα1
Agonisti: GDNF
Liatermin
Inhibitori kinaze : Vandetanib
GFRα2 GFRα3
Agonisti: Artemin (ARTN)
Inhibitori kinaze : Vandetanib
GFRα4
Agonisti: Perzefin (PSPN)
Inhibitori kinaze : Vandetanib
Unsorted
SCF (c-Kit)
Agonisti: Ancestim
Faktor matične ćelije
Inhibitori kinaze : Agerafenib
Axitinib
Dasatinib
Imatinib
Masitinib
Nilotinib
Pazopanib
Kvizartinib
Sorafenib
Sunitinib
Toceranib
TGFβ Trk
TrkA
Agonists: Amitriptylin
BNN-20
BNN-27
Cenegermin
DHEA
DHEA-S
Gambogid-amid
NGF
Tavilermid
Antagonisti: ALE-0540
Deksametazon
FX007
Testosterone
Negativni alosterni modulatori: VM-902A
Inhibitori kinaze :Altiratinib
AZD-6918
CE-245677
CH-7057288
DS-6051
Entrektinib
GZ-389988
K252a
Larotrectinib
Lestaurtinib
Milciclib
ONO-4474
ONO-5390556
PLX-7486
Rebastinib
SNA-120 (pegilatni K252a))
Antitijela : protiv TrkA: GBR-900; protiv NGF: ABT-110 (PG110)
ASP-6294
Fasinumab
Frunevetmab
Fulranumab
MEDI-578
Ranevetmab
Tanezumab
Aptameri: protiv NGF: RBM-004
Mamac-receptori: ReN-1820 (TrkAd5)
TrkB
Agonists: 3,7-DHF
3,7,8,2'-THF
4'-DMA-7,8-DHF
7,3'-DHF
7,8-DHF
7,8,2'-THF
7,8,3'-THF
Amitriptilin
BDNF
BNN-20
Dezoksigedunin
Deprenil
Diosmetin
DMAQ-B1
HIOC
LM22A-4
N-Acetilserotonin
NT-3
NT-4
Norvogonin (5,7,8-THF)
R7
R13
TDP6
Antagonisti: ANA-12
Ciklotraksin B
Gosipetin (3,5,7,8,3',4'-HHF)
Ligandi : DHEA
Inhibitori kinaze : Altiratinib
AZD-6918
CE-245677
CH-7057288
DS-6051
Entrectinib
GZ-389988
K252a
Larotrektinib
Lestaurtinib
ONO-4474
ONO-5390556
PLX-7486
TrkC
Agonisti: BNN-20
DHEA
NT-3
Inhibitori kinaze : Altiratinib
AZD-6918
CE-245677
CH-7057288
DS-6051
Entrectinib
GZ-389988
K252a
Larotrektinib
Lestaurtinib
ONO-4474
ONO-5390556
PLX-7486
VEGF
Agonisti: PGF
Ripretinib
Telbermin
VEGF (A, B, C, D (FIGF)
Alosterni modulatori: Ciklotraksin B
Inhibiztori kinaze : Agerafenib
Altiratinib
Aksitinib
Kabozantinib
Cediranib
Lapatinib
Lenvatinib
Motesanib
Nintedanib
Pazopanib
Pegaptanib
Rebastinib
Regorafenib
Semaxanib
Sorafenib
Sunitinib
Tokeranib
Tivozanib
Vandetanib
WHI-P 154
Antitijela : Alacizumab-pegol
Bevacizumab
Icrucumab
Ramucirumab
Ranibizumab
Receptori raspada: Aflibercept
Ostali
Dodatni faktori rasta : Adrenomedulin
Faktor stimuliranja kolonija (vidi Ovdje )
CTGF
Efrini (A1, A2, A3, A4, A5, B1, B2, B3)
Eritropoetin (vidi Ovdje )
GPI; PGI, PHI, AMF)
GMF
HDGF
Interleukini /T-ćelijski faktor rasta (vidi Ovdje )
LIF
MSP
NEGF2
MSF; PRG4
Onkomodulin
PACA)
Plejotrophin
Renalaza
Trombopoetin (vidi Ovdje )
Wnt-signalni proteini
Dodatni modulatori receptora faktora rasta: Cerebrolizin (mješavina neurotrofina)